IL17A and Hypertension: Although we did not measure endothelin (ET) in our study, we consider it a potential marker and effector of vascular pathways in PIH: IL-17 may promote MMP activation and ET-1 maturation [59,60], and higher ET-1 levels and their association with symptom severity have been demonstrated in pregnant women with hypertension [55,59].